Although the role of NKCC2 in renal handling of glucose remains poorly defined, NKCC2AKO mice developed several aspects of MetS including increased basal glycemia, glucose intolerance and insulin resistance (Kelly et al., 2019), but not hypertension, at least when mice were young (Oppermann et al., 2007). Here, SLC12A1 is linked to metabolic syndrome.